3559 results for «240»

Filter By

3559 results

Upgrade to retrograde: when and how?

16 May 2024 – From EuroPCR 2024

This session delves into the decision-making for transitioning to a retrograde approach in CTO PCI, covering effective techniques and safety considerations for successful outcomes, through cases involving antegradely induced hematomas and ambiguous CTO caps, alongside severe distal atherosclerosis.

Upgrade to retrograde: when and how?

Essentials in the management of calcified coronary stenosis

16 May 2024 – From EuroPCR 2024

This session focuses on the essentials of managing calcified coronary stenosis, including diagnostic pitfalls, selection strategies for appropriate plaque modification devices, and the safe and effective adoption of specific tools and techniques. Through interactive case discussions, attendees will learn how to effectively evaluate and treat calcified...

Essentials in the management of calcified coronary stenosis

Antegrade CTO - LIVE case

16 May 2024 – From EuroPCR 2024

This session features a LIVE educational case from Netcare Sunninghill Hospital in Johannesburg, South Africa, focusing on the management of chronic total occlusions (CTOs) using an antegrade approach. Participants will learn how to identify CTO anatomy through dual injection, as well as how to perform IVUS-guided...

Antegrade CTO - LIVE case

Pacemaker lead and the tricuspid valve: navigating challenges for optimal care

16 May 2024 – From EuroPCR 2024

This session focuses on the complex interplay between pacemaker leads and the tricuspid valve, addressing the anatomical interactions, procedural challenges, and alternative pacing strategies. Attendees will gain a better understanding of the impact of pacemaker leads on tricuspid regurgitation, the techniques for lead implantation and extraction,...

Pacemaker lead and the tricuspid valve: navigating challenges for optimal care

Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly

16 May 2024 – From EuroPCR 2024

Discover how to select suitable patients for TEER of primary mitral regurgitation, tackle anatomical challenges, understand the technique's limits, and gain insights into managing complexities and identifying cases where TEER may not be ideal.

Edge-to-edge repair for primary mitral regurgitation: the good, the bad and the ugly

TAVI - Step by step

16 May 2024 – From EuroPCR 2024

This interactive session provides a step-by-step guide on performing minimalist TAVI procedures. Attendees will learn how to optimize TAVI for speed and safety, with a deep dive on the safest techniques for large-bore arterial access and vessel closure. Key topics include femoral access, fluoroscopic projections, crossing...

TAVI - Step by step

PCI to treat the bystander disease in STEMI patients: who, when and how?

16 May 2024 – From EuroPCR 2024

Watch this case-based session on PCI for STEMI to see how the guidelines are influenced by the COMPLETE trial. Learn why and how physiology can guide intermediate lesions, the importance of intracoronary imaging guidance, the value of complete revascularization in STEMI patients, the optimal method for...

PCI to treat the bystander disease in STEMI patients: who, when and how?

Intracoronary imaging to guide management in ACS

16 May 2024 – From EuroPCR 2024

This session focuses on the role of intracoronary imaging, specifically IVUS and OCT, in the management of Acute Coronary Syndrome (ACS). Participants will learn when intracoronary imaging can facilitate diagnosis and guide PCI, as well as discuss image interpretation in the setting of ACS.

Intracoronary imaging to guide management in ACS

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

16 May 2024 – From EuroPCR 2024

This session presents the first results of randomized trials investigating the use of advanced plaque modification techniques, such as rotational atherectomy, lithotripsy, and laser atherectomy, as well as the role of intracoronary imaging (OCT and IVUS) in guiding percutaneous coronary intervention (PCI). The session aims to...

First results of randomised trials on advanced plaque modification techniques and intracoronary imaging

Acute and chronic right ventricular failure: focus on the weak link

16 May 2024 – From EuroPCR 2024

This session discusses new diagnostic and therapeutic aspects of shock due to right ventricular infarction, explores why and how the failing right ventricle contributes to worsening heart failure, and examines device-based treatment opportunities for chronic right ventricular and tricuspid valve failure, including repair vs replacement. It...

Acute and chronic right ventricular failure: focus on the weak link

PCI of bifurcation lesions: management of complications - Part 1

16 May 2024 – From EuroPCR 2024

Explore strategies for managing complex PCI of bifurcation lesions through case discussions. From stent deformation and delicate diagonal wiring to wire fracture with snare failure, decoiled coronary guidewires, misplaced stents, spontaneous coronary artery dissection, and late tamponade after PCI, this session covers how to effectively respond...

Mastering Bifurcation PCI: Navigating the unexpected

Mitral and tricuspid hotline

16 May 2024 – From EuroPCR 2024

This session provides updates on the latest developments in transcatheter mitral and tricuspid valve interventions. Key topics include one-year outcomes of the MiCLASP study on transcatheter mitral repair, the impact of residual mitral and tricuspid regurgitation after transcatheter repair, and the early feasibility of the AltaValve...

Mitral and tricuspid hotline

From machine learning to redo-TAVR: Pioneering abstracts unveiled

16 May 2024 – From EuroPCR 2024

This session features selected abstract submissions from EuroPCR 2024, showcasing the latest innovations and research in interventional cardiology. The presenters will have the opportunity to share their work and receive feedback from the audience, fostering collaboration and the exchange of ideas within the interventional cardiology community.

From machine learning to redo-TAVR: Pioneering abstracts unveiled

Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

30 Aug 2023

Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.

Alessandro Sticchi

Author

Alessandro Sticchi
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

06 Nov 2021

TCT 2021: Radoslaw Parma reviews the CHOICE-CLOSURE multicentre, randomized, controlled, open-label clinical trial presented by Mohamed Abdel-Wahab. The study compared outcomes of percutaneous femoral artery closure using a plug-based and a primary suture-based strategy in patients undergoing TAVI.

Author

Radoslaw Parma
CHOICE-CLOSURE: a randomized trial of plug-based versus suture-based large-bore vascular closure

INFINITY-SWEDEHEART - Percutaneous coronary intervention with a bioadaptor compared to a contemporary drug eluting stent- one year primary outcomes

03 Sep 2024

Daniele Giacoppo provides his take on the main results of the INFINITY-SWEDEHEART trial presented by David Erlinge at the ESC Congress 2024 in London.

Daniele Giacoppo

Author

Daniele Giacoppo
INFINITY-SWEDEHEART

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Best of #AHA20 Interventional Trials

19 Nov 2020

Mirvat Al Asnag provides reviews and take-home messages from a selection of major Late-breaking Clinical Trials in Interventional Cardiology released at the 2020 virtual edition of the American Heart Association Congress.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Best of #AHA20 Interventional Trials
Didn’t find what you were looking for?